DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies

Journal Article · · Science
ORCiD logo [1]; ORCiD logo [2]; ORCiD logo [3]; ORCiD logo [4]; ORCiD logo [1];  [1]; ORCiD logo [5]; ORCiD logo [2];  [2]; ORCiD logo [2];  [6]; ORCiD logo [6]; ORCiD logo [6];  [1]; ORCiD logo [1]; ORCiD logo [1]; ORCiD logo [1]; ORCiD logo [7]; ORCiD logo [8]; ORCiD logo [9] more »;  [1]; ORCiD logo [1];  [10]; ORCiD logo [10];  [10];  [10]; ORCiD logo [10]; ORCiD logo [11]; ORCiD logo [12];  [3]; ORCiD logo [6]; ORCiD logo [1]; ORCiD logo [2]; ORCiD logo [1] « less
  1. Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany); German Center for Neurodegenerative Diseases (DZNE), Berlin (Germany); Helmholtz Innovation Laboratory BaoBab (Brain Antibody-omics and B-cell Laboratory), Berlin (Germany)
  2. Scripps Research Institute, La Jolla, CA (United States)
  3. Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany); German Center for Neurodegenerative Diseases (DZNE), Berlin (Germany)
  4. Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany); German Centre for Infection Research (DZIF), Berlin (Germany); Labor Berlin-Charité Vivantes GmbH, Berlin (Germany)
  5. German Center for Neurodegenerative Diseases (DZNE), Berlin (Germany); Helmholtz Innovation Laboratory BaoBab (Brain Antibody-omics and B-cell Laboratory), Berlin (Germany)
  6. Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany); German Centre for Infection Research (DZIF), Berlin (Germany)
  7. Helmholtz Innovation Laboratory BaoBab (Brain Antibody-omics and B-cell Laboratory), Berlin (Germany)
  8. Charité–Universitätsmedizin, Berlin (Germany)
  9. Freie Universität, Berlin (Germany); Humboldt University of Berlin (Germany)
  10. Medical Center of the University of Munich (LMU) (Germany); German Center for Infection Research (DZIF), Munich (Germany)
  11. BKH Schwaz (Austria)
  12. Medical University of Innsbruck (Austria)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant of concern (VOC) resists neutralization by major classes of antibodies from COVID-19 patients and vaccinated individuals. In this study, serum of Beta-infected patients revealed reduced cross-neutralization of wild-type virus. From these patients, we isolated Beta-specific and cross-reactive receptor-binding domain (RBD) antibodies. The Beta-specificity results from recruitment of VOC-specific clonotypes and accommodation of mutations present in Beta and Omicron into a major antibody class that is normally sensitive to these mutations. The Beta-elicited cross-reactive antibodies share genetic and structural features with wild type–elicited antibodies, including a public VH1-58 clonotype that targets the RBD ridge. These findings advance our understanding of the antibody response to SARS-CoV-2 shaped by antigenic drift, with implications for design of next-generation vaccines and therapeutics.

Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States). Advanced Light Source (ALS)
Sponsoring Organization:
Austrian Science Fund (FWF); Bill and Melinda Gates Foundation; German Research Foundation (DFG); National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF); USDOE Office of Science (SC), Biological and Environmental Research (BER)
Grant/Contract Number:
AC02-05CH11231; AC02-76SF00515
OSTI ID:
1982958
Journal Information:
Science, Journal Name: Science Journal Issue: 6582 Vol. 375; ISSN 0036-8075
Publisher:
AAASCopyright Statement
Country of Publication:
United States
Language:
English

References (43)

[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study journal November 2021
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies journal January 2021
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies journal August 2020
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients journal September 2020
A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model journal November 2020
The antigenic anatomy of SARS-CoV-2 receptor binding domain journal April 2021
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera journal April 2021
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies journal April 2021
Antibody evasion by the P.1 strain of SARS-CoV-2 journal March 2021
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants journal September 2021
An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain journal October 2020
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class journal April 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination journal July 2021
A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection journal May 2021
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic journal July 2021
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning journal January 2008
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
SARS-CoV-2 variants, spike mutations and immune escape journal June 2021
Virological assessment of hospitalized patients with COVID-2019 journal April 2020
Convergent antibody responses to SARS-CoV-2 in convalescent individuals journal June 2020
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies journal October 2020
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants journal February 2021
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 journal March 2021
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity journal October 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift journal December 2021
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies journal March 2021
CoV-AbDab: the coronavirus antibody database journal August 2020
circlize implements and enhances circular visualization in R journal June 2014
Human cerebrospinal fluid monoclonal N -methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis journal August 2016
Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro journal June 2021
Phaser crystallographic software journal July 2007
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses journal July 2011
Structural basis of a shared antibody response to SARS-CoV-2 journal July 2020
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms journal September 2020
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants journal August 2021
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants journal July 2021
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients journal May 2021
Brain antibody sequence evaluation (BASE): an easy-to-use software for complete data analysis in single cell immunoglobulin cloning journal October 2020
Individual Variation in the Germline Ig Gene Repertoire Inferred from Variable Region Gene Rearrangements journal May 2010